Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 1 Trials

Baltimore, Maryland

Phase 1 colorectal cancer trials in Baltimore, MD

14 Phase 1 colorectal cancer studies are recruiting participants at sites in Baltimore as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.

Call (888) 415-5976
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Baltimore at a glance

  • 14 studies are recruiting at a site in Baltimore.
  • By phase: Phase 1 (7), Phase 1/2 (7).
  • By sponsor: industry (12), government (1), university, hospital or other (1).
  • Most recent update to one of these records: November 10, 2026.

Studies recruiting in Baltimore

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    Johns Hopkins University
    Registry record
    NCT07020221 · updated
  2. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Parabilis Medicines, Inc.
    Study site
    Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center
    Registry record
    NCT05919264 · updated
  3. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Exelixis
    Study site
    Exelixis Clinical Site #14
    Registry record
    NCT05176483 · updated
  4. Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    The Sidney Kimmel Comprehensive Cancer Center at John Hopkins
    Registry record
    NCT06445062 · updated
  5. Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Johns Hopkins
    Registry record
    NCT07349537 · updated
  6. Safety of HRX215 in Patients After Minor and Major Liver Resection

    • Phase 1/2
    • Ages 18 to 75
    • All sexes
    Sponsor
    HepaRegeniX GmbH
    Study site
    Johns Hopkins Hospital
    Registry record
    NCT06638502 · updated
  7. Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    Johns Hopkins University/Sidney Kimmel Cancer Center · University of Maryland/Greenebaum Cancer Center
    Registry record
    NCT07147231 · updated
  8. KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Study site
    Sidney Kimmel Comprehensive Cancer Center
    Registry record
    NCT06411691 · updated
  9. A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Seagen, a wholly owned subsidiary of Pfizer
    Study site
    Sidney Kimmel Comprehensive Cancer at Johns Hopkins
    Registry record
    NCT06131840 · updated
  10. A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Incyte Corporation
    Study site
    Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins
    Registry record
    NCT06179160 · updated
  11. Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Johns Hopkins University
    Registry record
    NCT06040541 · updated
  12. A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Johns Hopkins Hospital
    Registry record
    NCT07223047 · updated
  13. Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Johns Hopkins University
    Registry record
    NCT05379985 · updated
  14. A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Clasp Therapeutics, Inc.
    Study site
    Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center
    Registry record
    NCT06778863 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Baltimore, MD on ClinicalTrials.gov.

Ask about studies near Baltimore

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 415-5976

or send a short form

How should we reach you?

Call